UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. RTOG 1115: Phase III trial of dose escalated radiation therapy and standard androgen deprivation therapy (ADT) with a GnRH agonist vs. dose escalated radiation therapy and enhanced ADT with a GnRH ago…
    Mark C. Smith
  2. A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Ch…
    Alexandra Thomas
  3. Central vs Peripheral Sensitization and the Role of Individual Difference in Acute Myalgia
    Laura Frey Law
  4. Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination With Erlotinib in Papillary Renal Cell Carcinoma
    Daniel Vaena
  5. In vitro PK studies in prostate cancer for aptamer development
    Daniel Vaena
  6. A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
    John Buatti
  7. A randomized phase II study of Azacitidine in combination with Lenalidomide (NSC-703812) vs Azacitidine alone vs Azacitidine in combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic…
    Thomas Carter
  8. A Phase 2 Study of MLN8237 in Advanced / Metastatic Sarcoma
    Mohammed Milhem
  9. A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
    Ayman El-Sheikh
  10. A Phase II Evaluation of Dalantercept (NSC #757172, IND #116598), A Novel Soluble Recombinant Activin Receptor-Like Kinase 1 (ALK-1) Inhibitor Receptor-Fusion Protein, in the Treatment of Persistent o…
    David Bender
  11. A multi-center, open-label, single-arm, Phase 3b study of macitentan in patients with Pulmonary Arterial Hypertension to psychometrically validate the PAH-SYMPACT instrument
    Linda Cadaret
  12. A Randomized Phase III Trial Evaluating Pathologic Complete Response Rates in Patients with Hormone Receptor-Positive, HER2-Positive, Large Operable and Locally Advanced Breast Cancer Treated w
    Alexandra Thomas
  13. A Phase III, Multi-center, Open-label, Randomized, Controlled Study of the Efficacy and Safety of Oral LDE225 Versus Temozolomide in Patients With Hh-pathway Activated Relapsed Medulloblastoma
    Sue O'Dorisio
  14. Prospective Randomized Phase II Trial of Pazopanib (NSC #737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors
    Nancy Sharma
  15. PARACHUTE IV: Percutaneous Ventricular Restoration in Chronic Heart Failure due to Ischmic Heart Disease. A Pivotal Trial to Establish Efficacy and Long-term Safety of the Parachute implant system
    Vladamir Cotarlan
  16. Inflammation Inhibition for Microvascular and Autonomic Dysfunction in Obese Prediabetic Humans (INCITE)
    Gary L. Pierce
  17. Investigational Vaccine for Melanoma
    Mohammed Milhem
  18. A Phase 1b/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
    Daniel Vaena
  19. Combination of Chemotherapy Drugs for Women with HER2-Negative Breast Cancer
    Mark Karwal
  20. Effectiveness of the Drug BIBF 1120 in Treating Endometrial Cancer
    David Bender

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.